Docetaxel in Head and Neck Cancer

NCT00261703 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

439

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Neoplasms

Interventions

DRUG: Docetaxel, Cisplatin, 5-fluorouracil (5-FU), radiotherapy
DRUG: Cisplatin, 5-fluorouracil (5-FU), radiotherapy
OTHER: Cisplatin + radiotherapy

Sponsor

Sanofi